Kazia Therapeutics Limited
Kazia Therapeutics Limited KZA.AX Peers
See (KZA.AX) competitors and their performances in Stock Market.
Peer Comparison Table: Biotechnology Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| KZA.AX | $0.08 | +9.59% | 18.9M | -0.73 | -$0.11 | N/A |
| CSL.AX | $247.05 | +0.27% | 119.6B | 29.13 | $8.48 | +1.72% |
| TLX.AX | $25.84 | +1.37% | 8.7B | 184.57 | $0.14 | N/A |
| MSB.AX | $1.62 | -5.28% | 2.1B | -12.42 | -$0.13 | N/A |
| NEU.AX | $13.45 | +4.51% | 1.7B | 12.34 | $1.09 | N/A |
| OPT.AX | $0.60 | N/A | 738.8M | -1.36 | -$0.44 | N/A |
| PYC.AX | $1.23 | +2.50% | 717.4M | -11.18 | -$0.11 | N/A |
| BOT.AX | $0.37 | +2.82% | 715.7M | -18.25 | -$0.02 | N/A |
| CU6.AX | $2.21 | +0.45% | 710.2M | -13.81 | -$0.16 | N/A |
| CUV.AX | $10.43 | -2.07% | 522.8M | 13.55 | $0.77 | +0.48% |
Stock Comparison
KZA.AX vs CSL.AX Comparison
KZA.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KZA.AX stands at 18.9M. In comparison, CSL.AX has a market cap of 119.6B. Regarding current trading prices, KZA.AX is priced at $0.08, while CSL.AX trades at $247.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KZA.AX currently has a P/E ratio of -0.73, whereas CSL.AX's P/E ratio is 29.13. In terms of profitability, KZA.AX's ROE is -1.33%, compared to CSL.AX's ROE of +0.15%. Regarding short-term risk, KZA.AX is more volatile compared to CSL.AX. This indicates potentially higher risk in terms of short-term price fluctuations for KZA.AX.
KZA.AX vs TLX.AX Comparison
KZA.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KZA.AX stands at 18.9M. In comparison, TLX.AX has a market cap of 8.7B. Regarding current trading prices, KZA.AX is priced at $0.08, while TLX.AX trades at $25.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KZA.AX currently has a P/E ratio of -0.73, whereas TLX.AX's P/E ratio is 184.57. In terms of profitability, KZA.AX's ROE is -1.33%, compared to TLX.AX's ROE of +0.06%. Regarding short-term risk, KZA.AX is more volatile compared to TLX.AX. This indicates potentially higher risk in terms of short-term price fluctuations for KZA.AX.
KZA.AX vs MSB.AX Comparison
KZA.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KZA.AX stands at 18.9M. In comparison, MSB.AX has a market cap of 2.1B. Regarding current trading prices, KZA.AX is priced at $0.08, while MSB.AX trades at $1.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KZA.AX currently has a P/E ratio of -0.73, whereas MSB.AX's P/E ratio is -12.42. In terms of profitability, KZA.AX's ROE is -1.33%, compared to MSB.AX's ROE of -0.22%. Regarding short-term risk, KZA.AX is more volatile compared to MSB.AX. This indicates potentially higher risk in terms of short-term price fluctuations for KZA.AX.
KZA.AX vs NEU.AX Comparison
KZA.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KZA.AX stands at 18.9M. In comparison, NEU.AX has a market cap of 1.7B. Regarding current trading prices, KZA.AX is priced at $0.08, while NEU.AX trades at $13.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KZA.AX currently has a P/E ratio of -0.73, whereas NEU.AX's P/E ratio is 12.34. In terms of profitability, KZA.AX's ROE is -1.33%, compared to NEU.AX's ROE of +0.49%. Regarding short-term risk, KZA.AX is more volatile compared to NEU.AX. This indicates potentially higher risk in terms of short-term price fluctuations for KZA.AX.
KZA.AX vs OPT.AX Comparison
KZA.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KZA.AX stands at 18.9M. In comparison, OPT.AX has a market cap of 738.8M. Regarding current trading prices, KZA.AX is priced at $0.08, while OPT.AX trades at $0.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KZA.AX currently has a P/E ratio of -0.73, whereas OPT.AX's P/E ratio is -1.36. In terms of profitability, KZA.AX's ROE is -1.33%, compared to OPT.AX's ROE of +5.43%. Regarding short-term risk, KZA.AX is more volatile compared to OPT.AX. This indicates potentially higher risk in terms of short-term price fluctuations for KZA.AX.
KZA.AX vs PYC.AX Comparison
KZA.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KZA.AX stands at 18.9M. In comparison, PYC.AX has a market cap of 717.4M. Regarding current trading prices, KZA.AX is priced at $0.08, while PYC.AX trades at $1.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KZA.AX currently has a P/E ratio of -0.73, whereas PYC.AX's P/E ratio is -11.18. In terms of profitability, KZA.AX's ROE is -1.33%, compared to PYC.AX's ROE of -0.71%. Regarding short-term risk, KZA.AX is more volatile compared to PYC.AX. This indicates potentially higher risk in terms of short-term price fluctuations for KZA.AX.
KZA.AX vs BOT.AX Comparison
KZA.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KZA.AX stands at 18.9M. In comparison, BOT.AX has a market cap of 715.7M. Regarding current trading prices, KZA.AX is priced at $0.08, while BOT.AX trades at $0.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KZA.AX currently has a P/E ratio of -0.73, whereas BOT.AX's P/E ratio is -18.25. In terms of profitability, KZA.AX's ROE is -1.33%, compared to BOT.AX's ROE of -0.39%. Regarding short-term risk, KZA.AX is more volatile compared to BOT.AX. This indicates potentially higher risk in terms of short-term price fluctuations for KZA.AX.
KZA.AX vs CU6.AX Comparison
KZA.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KZA.AX stands at 18.9M. In comparison, CU6.AX has a market cap of 710.2M. Regarding current trading prices, KZA.AX is priced at $0.08, while CU6.AX trades at $2.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KZA.AX currently has a P/E ratio of -0.73, whereas CU6.AX's P/E ratio is -13.81. In terms of profitability, KZA.AX's ROE is -1.33%, compared to CU6.AX's ROE of -0.36%. Regarding short-term risk, KZA.AX is more volatile compared to CU6.AX. This indicates potentially higher risk in terms of short-term price fluctuations for KZA.AX.
KZA.AX vs CUV.AX Comparison
KZA.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KZA.AX stands at 18.9M. In comparison, CUV.AX has a market cap of 522.8M. Regarding current trading prices, KZA.AX is priced at $0.08, while CUV.AX trades at $10.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KZA.AX currently has a P/E ratio of -0.73, whereas CUV.AX's P/E ratio is 13.55. In terms of profitability, KZA.AX's ROE is -1.33%, compared to CUV.AX's ROE of +0.18%. Regarding short-term risk, KZA.AX is more volatile compared to CUV.AX. This indicates potentially higher risk in terms of short-term price fluctuations for KZA.AX.
KZA.AX vs IMM.AX Comparison
KZA.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KZA.AX stands at 18.9M. In comparison, IMM.AX has a market cap of 408.9M. Regarding current trading prices, KZA.AX is priced at $0.08, while IMM.AX trades at $0.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KZA.AX currently has a P/E ratio of -0.73, whereas IMM.AX's P/E ratio is -7.00. In terms of profitability, KZA.AX's ROE is -1.33%, compared to IMM.AX's ROE of -0.35%. Regarding short-term risk, KZA.AX is more volatile compared to IMM.AX. This indicates potentially higher risk in terms of short-term price fluctuations for KZA.AX.
KZA.AX vs DXB.AX Comparison
KZA.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KZA.AX stands at 18.9M. In comparison, DXB.AX has a market cap of 345.7M. Regarding current trading prices, KZA.AX is priced at $0.08, while DXB.AX trades at $0.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KZA.AX currently has a P/E ratio of -0.73, whereas DXB.AX's P/E ratio is -14.87. In terms of profitability, KZA.AX's ROE is -1.33%, compared to DXB.AX's ROE of -1.84%. Regarding short-term risk, KZA.AX is more volatile compared to DXB.AX. This indicates potentially higher risk in terms of short-term price fluctuations for KZA.AX.
KZA.AX vs OCC.AX Comparison
KZA.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KZA.AX stands at 18.9M. In comparison, OCC.AX has a market cap of 303.7M. Regarding current trading prices, KZA.AX is priced at $0.08, while OCC.AX trades at $1.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KZA.AX currently has a P/E ratio of -0.73, whereas OCC.AX's P/E ratio is -62.75. In terms of profitability, KZA.AX's ROE is -1.33%, compared to OCC.AX's ROE of -0.27%. Regarding short-term risk, KZA.AX is more volatile compared to OCC.AX. This indicates potentially higher risk in terms of short-term price fluctuations for KZA.AX.
KZA.AX vs RAC.AX Comparison
KZA.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KZA.AX stands at 18.9M. In comparison, RAC.AX has a market cap of 240.6M. Regarding current trading prices, KZA.AX is priced at $0.08, while RAC.AX trades at $1.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KZA.AX currently has a P/E ratio of -0.73, whereas RAC.AX's P/E ratio is -27.70. In terms of profitability, KZA.AX's ROE is -1.33%, compared to RAC.AX's ROE of -0.39%. Regarding short-term risk, KZA.AX is more volatile compared to RAC.AX. This indicates potentially higher risk in terms of short-term price fluctuations for KZA.AX.
KZA.AX vs IMU.AX Comparison
KZA.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KZA.AX stands at 18.9M. In comparison, IMU.AX has a market cap of 126.9M. Regarding current trading prices, KZA.AX is priced at $0.08, while IMU.AX trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KZA.AX currently has a P/E ratio of -0.73, whereas IMU.AX's P/E ratio is -0.85. In terms of profitability, KZA.AX's ROE is -1.33%, compared to IMU.AX's ROE of -1.42%. Regarding short-term risk, KZA.AX is more volatile compared to IMU.AX. This indicates potentially higher risk in terms of short-term price fluctuations for KZA.AX.
KZA.AX vs PAR.AX Comparison
KZA.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KZA.AX stands at 18.9M. In comparison, PAR.AX has a market cap of 124.6M. Regarding current trading prices, KZA.AX is priced at $0.08, while PAR.AX trades at $0.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KZA.AX currently has a P/E ratio of -0.73, whereas PAR.AX's P/E ratio is -6.40. In terms of profitability, KZA.AX's ROE is -1.33%, compared to PAR.AX's ROE of -0.54%. Regarding short-term risk, KZA.AX is more volatile compared to PAR.AX. This indicates potentially higher risk in terms of short-term price fluctuations for KZA.AX.
KZA.AX vs PAA.AX Comparison
KZA.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KZA.AX stands at 18.9M. In comparison, PAA.AX has a market cap of 111.9M. Regarding current trading prices, KZA.AX is priced at $0.08, while PAA.AX trades at $0.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KZA.AX currently has a P/E ratio of -0.73, whereas PAA.AX's P/E ratio is -11.50. In terms of profitability, KZA.AX's ROE is -1.33%, compared to PAA.AX's ROE of -0.87%. Regarding short-term risk, KZA.AX is more volatile compared to PAA.AX. This indicates potentially higher risk in terms of short-term price fluctuations for KZA.AX.
KZA.AX vs AGN.AX Comparison
KZA.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KZA.AX stands at 18.9M. In comparison, AGN.AX has a market cap of 105.7M. Regarding current trading prices, KZA.AX is priced at $0.08, while AGN.AX trades at $0.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KZA.AX currently has a P/E ratio of -0.73, whereas AGN.AX's P/E ratio is -16.50. In terms of profitability, KZA.AX's ROE is -1.33%, compared to AGN.AX's ROE of -0.39%. Regarding short-term risk, KZA.AX is more volatile compared to AGN.AX. This indicates potentially higher risk in terms of short-term price fluctuations for KZA.AX.
KZA.AX vs ATH.AX Comparison
KZA.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KZA.AX stands at 18.9M. In comparison, ATH.AX has a market cap of 100.4M. Regarding current trading prices, KZA.AX is priced at $0.08, while ATH.AX trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KZA.AX currently has a P/E ratio of -0.73, whereas ATH.AX's P/E ratio is -0.55. In terms of profitability, KZA.AX's ROE is -1.33%, compared to ATH.AX's ROE of -1.83%. Regarding short-term risk, KZA.AX is more volatile compared to ATH.AX. This indicates potentially higher risk in terms of short-term price fluctuations for KZA.AX.
KZA.AX vs BIO.AX Comparison
KZA.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KZA.AX stands at 18.9M. In comparison, BIO.AX has a market cap of 89.9M. Regarding current trading prices, KZA.AX is priced at $0.08, while BIO.AX trades at $0.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KZA.AX currently has a P/E ratio of -0.73, whereas BIO.AX's P/E ratio is -41.00. In terms of profitability, KZA.AX's ROE is -1.33%, compared to BIO.AX's ROE of +0.08%. Regarding short-term risk, KZA.AX is more volatile compared to BIO.AX. This indicates potentially higher risk in terms of short-term price fluctuations for KZA.AX.
KZA.AX vs ALA.AX Comparison
KZA.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KZA.AX stands at 18.9M. In comparison, ALA.AX has a market cap of 87.6M. Regarding current trading prices, KZA.AX is priced at $0.08, while ALA.AX trades at $0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KZA.AX currently has a P/E ratio of -0.73, whereas ALA.AX's P/E ratio is -7.40. In terms of profitability, KZA.AX's ROE is -1.33%, compared to ALA.AX's ROE of -0.55%. Regarding short-term risk, KZA.AX is more volatile compared to ALA.AX. This indicates potentially higher risk in terms of short-term price fluctuations for KZA.AX.
KZA.AX vs RCE.AX Comparison
KZA.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KZA.AX stands at 18.9M. In comparison, RCE.AX has a market cap of 77.3M. Regarding current trading prices, KZA.AX is priced at $0.08, while RCE.AX trades at $0.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KZA.AX currently has a P/E ratio of -0.73, whereas RCE.AX's P/E ratio is -3.28. In terms of profitability, KZA.AX's ROE is -1.33%, compared to RCE.AX's ROE of +2.47%. Regarding short-term risk, KZA.AX is more volatile compared to RCE.AX. This indicates potentially higher risk in terms of short-term price fluctuations for KZA.AX.
KZA.AX vs EZZ.AX Comparison
KZA.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KZA.AX stands at 18.9M. In comparison, EZZ.AX has a market cap of 72.6M. Regarding current trading prices, KZA.AX is priced at $0.08, while EZZ.AX trades at $1.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KZA.AX currently has a P/E ratio of -0.73, whereas EZZ.AX's P/E ratio is 7.33. In terms of profitability, KZA.AX's ROE is -1.33%, compared to EZZ.AX's ROE of +0.40%. Regarding short-term risk, KZA.AX is more volatile compared to EZZ.AX. This indicates potentially higher risk in terms of short-term price fluctuations for KZA.AX.
KZA.AX vs ACW.AX Comparison
KZA.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KZA.AX stands at 18.9M. In comparison, ACW.AX has a market cap of 63.5M. Regarding current trading prices, KZA.AX is priced at $0.08, while ACW.AX trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KZA.AX currently has a P/E ratio of -0.73, whereas ACW.AX's P/E ratio is -2.00. In terms of profitability, KZA.AX's ROE is -1.33%, compared to ACW.AX's ROE of -0.44%. Regarding short-term risk, KZA.AX is less volatile compared to ACW.AX. This indicates potentially lower risk in terms of short-term price fluctuations for KZA.AX.
KZA.AX vs PIQ.AX Comparison
KZA.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KZA.AX stands at 18.9M. In comparison, PIQ.AX has a market cap of 57.4M. Regarding current trading prices, KZA.AX is priced at $0.08, while PIQ.AX trades at $0.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KZA.AX currently has a P/E ratio of -0.73, whereas PIQ.AX's P/E ratio is -6.75. In terms of profitability, KZA.AX's ROE is -1.33%, compared to PIQ.AX's ROE of -0.96%. Regarding short-term risk, KZA.AX is more volatile compared to PIQ.AX. This indicates potentially higher risk in terms of short-term price fluctuations for KZA.AX.
KZA.AX vs RAD.AX Comparison
KZA.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KZA.AX stands at 18.9M. In comparison, RAD.AX has a market cap of 56M. Regarding current trading prices, KZA.AX is priced at $0.08, while RAD.AX trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KZA.AX currently has a P/E ratio of -0.73, whereas RAD.AX's P/E ratio is -0.40. In terms of profitability, KZA.AX's ROE is -1.33%, compared to RAD.AX's ROE of -1.03%. Regarding short-term risk, KZA.AX is more volatile compared to RAD.AX. This indicates potentially higher risk in terms of short-term price fluctuations for KZA.AX.
KZA.AX vs ILA.AX Comparison
KZA.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KZA.AX stands at 18.9M. In comparison, ILA.AX has a market cap of 50.5M. Regarding current trading prices, KZA.AX is priced at $0.08, while ILA.AX trades at $0.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KZA.AX currently has a P/E ratio of -0.73, whereas ILA.AX's P/E ratio is -8.00. In terms of profitability, KZA.AX's ROE is -1.33%, compared to ILA.AX's ROE of -1.20%. Regarding short-term risk, KZA.AX is more volatile compared to ILA.AX. This indicates potentially higher risk in terms of short-term price fluctuations for KZA.AX.
KZA.AX vs CYP.AX Comparison
KZA.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KZA.AX stands at 18.9M. In comparison, CYP.AX has a market cap of 40.7M. Regarding current trading prices, KZA.AX is priced at $0.08, while CYP.AX trades at $0.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KZA.AX currently has a P/E ratio of -0.73, whereas CYP.AX's P/E ratio is -3.60. In terms of profitability, KZA.AX's ROE is -1.33%, compared to CYP.AX's ROE of -0.95%. Regarding short-term risk, KZA.AX is more volatile compared to CYP.AX. This indicates potentially higher risk in terms of short-term price fluctuations for KZA.AX.
KZA.AX vs SPL.AX Comparison
KZA.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KZA.AX stands at 18.9M. In comparison, SPL.AX has a market cap of 37.6M. Regarding current trading prices, KZA.AX is priced at $0.08, while SPL.AX trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KZA.AX currently has a P/E ratio of -0.73, whereas SPL.AX's P/E ratio is -3.00. In terms of profitability, KZA.AX's ROE is -1.33%, compared to SPL.AX's ROE of -0.49%. Regarding short-term risk, KZA.AX is more volatile compared to SPL.AX. This indicates potentially higher risk in terms of short-term price fluctuations for KZA.AX.
KZA.AX vs PTX.AX Comparison
KZA.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KZA.AX stands at 18.9M. In comparison, PTX.AX has a market cap of 37M. Regarding current trading prices, KZA.AX is priced at $0.08, while PTX.AX trades at $0.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KZA.AX currently has a P/E ratio of -0.73, whereas PTX.AX's P/E ratio is -4.60. In terms of profitability, KZA.AX's ROE is -1.33%, compared to PTX.AX's ROE of -0.42%. Regarding short-term risk, KZA.AX is more volatile compared to PTX.AX. This indicates potentially higher risk in terms of short-term price fluctuations for KZA.AX.
KZA.AX vs NYR.AX Comparison
KZA.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KZA.AX stands at 18.9M. In comparison, NYR.AX has a market cap of 29.4M. Regarding current trading prices, KZA.AX is priced at $0.08, while NYR.AX trades at $0.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KZA.AX currently has a P/E ratio of -0.73, whereas NYR.AX's P/E ratio is -7.00. In terms of profitability, KZA.AX's ROE is -1.33%, compared to NYR.AX's ROE of -0.73%. Regarding short-term risk, KZA.AX is more volatile compared to NYR.AX. This indicates potentially higher risk in terms of short-term price fluctuations for KZA.AX.
KZA.AX vs LCT.AX Comparison
KZA.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KZA.AX stands at 18.9M. In comparison, LCT.AX has a market cap of 24.5M. Regarding current trading prices, KZA.AX is priced at $0.08, while LCT.AX trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KZA.AX currently has a P/E ratio of -0.73, whereas LCT.AX's P/E ratio is N/A. In terms of profitability, KZA.AX's ROE is -1.33%, compared to LCT.AX's ROE of -0.54%. Regarding short-term risk, KZA.AX is more volatile compared to LCT.AX. This indicates potentially higher risk in terms of short-term price fluctuations for KZA.AX.
KZA.AX vs ADO.AX Comparison
KZA.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KZA.AX stands at 18.9M. In comparison, ADO.AX has a market cap of 21.6M. Regarding current trading prices, KZA.AX is priced at $0.08, while ADO.AX trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KZA.AX currently has a P/E ratio of -0.73, whereas ADO.AX's P/E ratio is -0.80. In terms of profitability, KZA.AX's ROE is -1.33%, compared to ADO.AX's ROE of -1.34%. Regarding short-term risk, KZA.AX and ADO.AX have similar daily volatility (13.33).
KZA.AX vs ATX.AX Comparison
KZA.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KZA.AX stands at 18.9M. In comparison, ATX.AX has a market cap of 19.8M. Regarding current trading prices, KZA.AX is priced at $0.08, while ATX.AX trades at $0.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KZA.AX currently has a P/E ratio of -0.73, whereas ATX.AX's P/E ratio is -1.70. In terms of profitability, KZA.AX's ROE is -1.33%, compared to ATX.AX's ROE of -0.51%. Regarding short-term risk, KZA.AX is more volatile compared to ATX.AX. This indicates potentially higher risk in terms of short-term price fluctuations for KZA.AX.
KZA.AX vs NOX.AX Comparison
KZA.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KZA.AX stands at 18.9M. In comparison, NOX.AX has a market cap of 19.3M. Regarding current trading prices, KZA.AX is priced at $0.08, while NOX.AX trades at $0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KZA.AX currently has a P/E ratio of -0.73, whereas NOX.AX's P/E ratio is -6.60. In terms of profitability, KZA.AX's ROE is -1.33%, compared to NOX.AX's ROE of -0.47%. Regarding short-term risk, KZA.AX is more volatile compared to NOX.AX. This indicates potentially higher risk in terms of short-term price fluctuations for KZA.AX.
KZA.AX vs BTC.AX Comparison
KZA.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KZA.AX stands at 18.9M. In comparison, BTC.AX has a market cap of 17.6M. Regarding current trading prices, KZA.AX is priced at $0.08, while BTC.AX trades at $0.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KZA.AX currently has a P/E ratio of -0.73, whereas BTC.AX's P/E ratio is 5.40. In terms of profitability, KZA.AX's ROE is -1.33%, compared to BTC.AX's ROE of +0.58%. Regarding short-term risk, KZA.AX is more volatile compared to BTC.AX. This indicates potentially higher risk in terms of short-term price fluctuations for KZA.AX.
KZA.AX vs AVE.AX Comparison
KZA.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KZA.AX stands at 18.9M. In comparison, AVE.AX has a market cap of 15.9M. Regarding current trading prices, KZA.AX is priced at $0.08, while AVE.AX trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KZA.AX currently has a P/E ratio of -0.73, whereas AVE.AX's P/E ratio is N/A. In terms of profitability, KZA.AX's ROE is -1.33%, compared to AVE.AX's ROE of -0.83%. Regarding short-term risk, KZA.AX is more volatile compared to AVE.AX. This indicates potentially higher risk in terms of short-term price fluctuations for KZA.AX.
KZA.AX vs NC6.AX Comparison
KZA.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KZA.AX stands at 18.9M. In comparison, NC6.AX has a market cap of 15.9M. Regarding current trading prices, KZA.AX is priced at $0.08, while NC6.AX trades at $0.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KZA.AX currently has a P/E ratio of -0.73, whereas NC6.AX's P/E ratio is -5.20. In terms of profitability, KZA.AX's ROE is -1.33%, compared to NC6.AX's ROE of +3.42%. Regarding short-term risk, KZA.AX is more volatile compared to NC6.AX. This indicates potentially higher risk in terms of short-term price fluctuations for KZA.AX.
KZA.AX vs MDC.AX Comparison
KZA.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KZA.AX stands at 18.9M. In comparison, MDC.AX has a market cap of 15.1M. Regarding current trading prices, KZA.AX is priced at $0.08, while MDC.AX trades at $6.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KZA.AX currently has a P/E ratio of -0.73, whereas MDC.AX's P/E ratio is -0.01. In terms of profitability, KZA.AX's ROE is -1.33%, compared to MDC.AX's ROE of +2.75%. Regarding short-term risk, KZA.AX is more volatile compared to MDC.AX. This indicates potentially higher risk in terms of short-term price fluctuations for KZA.AX.
KZA.AX vs IMC.AX Comparison
KZA.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KZA.AX stands at 18.9M. In comparison, IMC.AX has a market cap of 14.7M. Regarding current trading prices, KZA.AX is priced at $0.08, while IMC.AX trades at $0.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KZA.AX currently has a P/E ratio of -0.73, whereas IMC.AX's P/E ratio is -2.10. In terms of profitability, KZA.AX's ROE is -1.33%, compared to IMC.AX's ROE of -0.64%. Regarding short-term risk, KZA.AX is more volatile compared to IMC.AX. This indicates potentially higher risk in terms of short-term price fluctuations for KZA.AX.
KZA.AX vs BNO.AX Comparison
KZA.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KZA.AX stands at 18.9M. In comparison, BNO.AX has a market cap of 13.2M. Regarding current trading prices, KZA.AX is priced at $0.08, while BNO.AX trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KZA.AX currently has a P/E ratio of -0.73, whereas BNO.AX's P/E ratio is -0.45. In terms of profitability, KZA.AX's ROE is -1.33%, compared to BNO.AX's ROE of -1.16%. Regarding short-term risk, KZA.AX is less volatile compared to BNO.AX. This indicates potentially lower risk in terms of short-term price fluctuations for KZA.AX.
KZA.AX vs TRP.AX Comparison
KZA.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KZA.AX stands at 18.9M. In comparison, TRP.AX has a market cap of 11.2M. Regarding current trading prices, KZA.AX is priced at $0.08, while TRP.AX trades at $0.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KZA.AX currently has a P/E ratio of -0.73, whereas TRP.AX's P/E ratio is -2.64. In terms of profitability, KZA.AX's ROE is -1.33%, compared to TRP.AX's ROE of -0.26%. Regarding short-term risk, KZA.AX is more volatile compared to TRP.AX. This indicates potentially higher risk in terms of short-term price fluctuations for KZA.AX.
KZA.AX vs MEM.AX Comparison
KZA.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KZA.AX stands at 18.9M. In comparison, MEM.AX has a market cap of 9.9M. Regarding current trading prices, KZA.AX is priced at $0.08, while MEM.AX trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KZA.AX currently has a P/E ratio of -0.73, whereas MEM.AX's P/E ratio is N/A. In terms of profitability, KZA.AX's ROE is -1.33%, compared to MEM.AX's ROE of -0.79%. Regarding short-term risk, KZA.AX is more volatile compared to MEM.AX. This indicates potentially higher risk in terms of short-term price fluctuations for KZA.AX.
KZA.AX vs ACR.AX Comparison
KZA.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KZA.AX stands at 18.9M. In comparison, ACR.AX has a market cap of 9.4M. Regarding current trading prices, KZA.AX is priced at $0.08, while ACR.AX trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KZA.AX currently has a P/E ratio of -0.73, whereas ACR.AX's P/E ratio is -1.15. In terms of profitability, KZA.AX's ROE is -1.33%, compared to ACR.AX's ROE of -1.79%. Regarding short-term risk, KZA.AX is more volatile compared to ACR.AX. This indicates potentially higher risk in terms of short-term price fluctuations for KZA.AX.
KZA.AX vs NSB.AX Comparison
KZA.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KZA.AX stands at 18.9M. In comparison, NSB.AX has a market cap of 7.7M. Regarding current trading prices, KZA.AX is priced at $0.08, while NSB.AX trades at $0.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KZA.AX currently has a P/E ratio of -0.73, whereas NSB.AX's P/E ratio is 5.30. In terms of profitability, KZA.AX's ROE is -1.33%, compared to NSB.AX's ROE of +0.23%. Regarding short-term risk, KZA.AX is more volatile compared to NSB.AX. This indicates potentially higher risk in terms of short-term price fluctuations for KZA.AX.
KZA.AX vs CHM.AX Comparison
KZA.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KZA.AX stands at 18.9M. In comparison, CHM.AX has a market cap of 7.4M. Regarding current trading prices, KZA.AX is priced at $0.08, while CHM.AX trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KZA.AX currently has a P/E ratio of -0.73, whereas CHM.AX's P/E ratio is -0.20. In terms of profitability, KZA.AX's ROE is -1.33%, compared to CHM.AX's ROE of -4.24%. Regarding short-term risk, KZA.AX is more volatile compared to CHM.AX. This indicates potentially higher risk in terms of short-term price fluctuations for KZA.AX.
KZA.AX vs IXC.AX Comparison
KZA.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KZA.AX stands at 18.9M. In comparison, IXC.AX has a market cap of 7M. Regarding current trading prices, KZA.AX is priced at $0.08, while IXC.AX trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KZA.AX currently has a P/E ratio of -0.73, whereas IXC.AX's P/E ratio is -4.65. In terms of profitability, KZA.AX's ROE is -1.33%, compared to IXC.AX's ROE of +0.02%. Regarding short-term risk, KZA.AX is more volatile compared to IXC.AX. This indicates potentially higher risk in terms of short-term price fluctuations for KZA.AX.
KZA.AX vs ZLD.AX Comparison
KZA.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KZA.AX stands at 18.9M. In comparison, ZLD.AX has a market cap of 5.9M. Regarding current trading prices, KZA.AX is priced at $0.08, while ZLD.AX trades at $0.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KZA.AX currently has a P/E ratio of -0.73, whereas ZLD.AX's P/E ratio is -1.18. In terms of profitability, KZA.AX's ROE is -1.33%, compared to ZLD.AX's ROE of +0.75%. Regarding short-term risk, KZA.AX is more volatile compared to ZLD.AX. This indicates potentially higher risk in terms of short-term price fluctuations for KZA.AX.
KZA.AX vs BGT.AX Comparison
KZA.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KZA.AX stands at 18.9M. In comparison, BGT.AX has a market cap of 5.8M. Regarding current trading prices, KZA.AX is priced at $0.08, while BGT.AX trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KZA.AX currently has a P/E ratio of -0.73, whereas BGT.AX's P/E ratio is -2.30. In terms of profitability, KZA.AX's ROE is -1.33%, compared to BGT.AX's ROE of -1.15%. Regarding short-term risk, KZA.AX is more volatile compared to BGT.AX. This indicates potentially higher risk in terms of short-term price fluctuations for KZA.AX.
KZA.AX vs PAB.AX Comparison
KZA.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KZA.AX stands at 18.9M. In comparison, PAB.AX has a market cap of 4.1M. Regarding current trading prices, KZA.AX is priced at $0.08, while PAB.AX trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KZA.AX currently has a P/E ratio of -0.73, whereas PAB.AX's P/E ratio is N/A. In terms of profitability, KZA.AX's ROE is -1.33%, compared to PAB.AX's ROE of -1.14%. Regarding short-term risk, KZA.AX is more volatile compared to PAB.AX. This indicates potentially higher risk in terms of short-term price fluctuations for KZA.AX.
KZA.AX vs BIT.AX Comparison
KZA.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KZA.AX stands at 18.9M. In comparison, BIT.AX has a market cap of 4M. Regarding current trading prices, KZA.AX is priced at $0.08, while BIT.AX trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KZA.AX currently has a P/E ratio of -0.73, whereas BIT.AX's P/E ratio is -0.30. In terms of profitability, KZA.AX's ROE is -1.33%, compared to BIT.AX's ROE of -13.17%. Regarding short-term risk, KZA.AX is less volatile compared to BIT.AX. This indicates potentially lower risk in terms of short-term price fluctuations for KZA.AX.
KZA.AX vs RGS.AX Comparison
KZA.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KZA.AX stands at 18.9M. In comparison, RGS.AX has a market cap of 3.7M. Regarding current trading prices, KZA.AX is priced at $0.08, while RGS.AX trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KZA.AX currently has a P/E ratio of -0.73, whereas RGS.AX's P/E ratio is -1.20. In terms of profitability, KZA.AX's ROE is -1.33%, compared to RGS.AX's ROE of +4.56%. Regarding short-term risk, KZA.AX is less volatile compared to RGS.AX. This indicates potentially lower risk in terms of short-term price fluctuations for KZA.AX.
KZA.AX vs 1AD.AX Comparison
KZA.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KZA.AX stands at 18.9M. In comparison, 1AD.AX has a market cap of 3.2M. Regarding current trading prices, KZA.AX is priced at $0.08, while 1AD.AX trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KZA.AX currently has a P/E ratio of -0.73, whereas 1AD.AX's P/E ratio is -0.30. In terms of profitability, KZA.AX's ROE is -1.33%, compared to 1AD.AX's ROE of -4.64%. Regarding short-term risk, KZA.AX is less volatile compared to 1AD.AX. This indicates potentially lower risk in terms of short-term price fluctuations for KZA.AX.
KZA.AX vs VBS.AX Comparison
KZA.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KZA.AX stands at 18.9M. In comparison, VBS.AX has a market cap of 3.2M. Regarding current trading prices, KZA.AX is priced at $0.08, while VBS.AX trades at $0.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KZA.AX currently has a P/E ratio of -0.73, whereas VBS.AX's P/E ratio is -1.50. In terms of profitability, KZA.AX's ROE is -1.33%, compared to VBS.AX's ROE of -2.39%. Regarding short-term risk, KZA.AX is more volatile compared to VBS.AX. This indicates potentially higher risk in terms of short-term price fluctuations for KZA.AX.
KZA.AX vs HXL.AX Comparison
KZA.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KZA.AX stands at 18.9M. In comparison, HXL.AX has a market cap of 2.2M. Regarding current trading prices, KZA.AX is priced at $0.08, while HXL.AX trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KZA.AX currently has a P/E ratio of -0.73, whereas HXL.AX's P/E ratio is -1.30. In terms of profitability, KZA.AX's ROE is -1.33%, compared to HXL.AX's ROE of -0.53%. Regarding short-term risk, KZA.AX is more volatile compared to HXL.AX. This indicates potentially higher risk in terms of short-term price fluctuations for KZA.AX.
KZA.AX vs EX1.AX Comparison
KZA.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KZA.AX stands at 18.9M. In comparison, EX1.AX has a market cap of 1.9M. Regarding current trading prices, KZA.AX is priced at $0.08, while EX1.AX trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KZA.AX currently has a P/E ratio of -0.73, whereas EX1.AX's P/E ratio is -0.12. In terms of profitability, KZA.AX's ROE is -1.33%, compared to EX1.AX's ROE of -1.61%. Regarding short-term risk, KZA.AX is more volatile compared to EX1.AX. This indicates potentially higher risk in terms of short-term price fluctuations for KZA.AX.
KZA.AX vs ANR.AX Comparison
KZA.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KZA.AX stands at 18.9M. In comparison, ANR.AX has a market cap of 1.1M. Regarding current trading prices, KZA.AX is priced at $0.08, while ANR.AX trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KZA.AX currently has a P/E ratio of -0.73, whereas ANR.AX's P/E ratio is -0.50. In terms of profitability, KZA.AX's ROE is -1.33%, compared to ANR.AX's ROE of -1.42%. Regarding short-term risk, KZA.AX is more volatile compared to ANR.AX. This indicates potentially higher risk in terms of short-term price fluctuations for KZA.AX.